CoChat

The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions

Open access
Nahrendorf, Matthias, Swirski, Filip K., Aikawa, Elena, Stangenberg, Lars, Wurdinger, Thomas, Figueiredo, Jose-Luiz, Libby, Peter, Weissleder, Ralph, Pittet, Mikael J. · 2007 · The Journal of Experimental Medicine

The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.

Abstract

Healing of myocardial infarction (MI) requires monocytes/macrophages. These mononuclear phagocytes likely degrade released macromolecules and aid in scavenging of dead cardiomyocytes, while mediating aspects of granulation tissue formation and remodeling. The mechanisms that orchestrate such divergent functions remain unknown. In view of the heightened appreciation of the heterogeneity of circulating monocytes, we investigated whether distinct monocyte subsets contribute in specific ways to myocardial ischemic injury in mouse MI. We identify two distinct phases of monocyte participation after MI and propose a model that reconciles the divergent properties of these cells in healing. Infarcted hearts modulate their chemokine expression profile over time, and they sequentially and actively recruit Ly-6Chi and -6Clo monocytes via CCR2 and CX3CR1, respectively. Ly-6Chi monocytes dominate early (phase I) and exhibit phagocytic, proteolytic, and inflammatory functions. Ly-6Clo monocytes dominate later (phase II), have attenuated inflammatory properties, and express vascular–endothelial growth factor. Consequently, Ly-6Chi monocytes digest damaged tissue, whereas Ly-6Clo monocytes promote healing via myofibroblast accumulation, angiogenesis, and deposition of collagen. MI in atherosclerotic mice with chronic Ly-6Chi monocytosis results in impaired healing, underscoring the need for a balanced and coordinated response. These observations provide novel mechanistic insights into the cellular and molecular events that regulate the response to ischemic injury and identify new therapeutic targets that can influence healing and ventricular remodeling after MI.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1084/jem.20070885

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. The ischemic myocardium mobilizes Ly-6Chi and -6Clo monocytes in two distinct phases. Cell suspensions from healthy hearts or infarcts of C57BL/6 mice were stained with anti-CD11b, -CD90, -B220, -CD49b, -NK1.1, -Ly-6G, -Ly-6C, -F4/80, -I-Ab, and -CD11c mAbs. Monocytes/macrophages/dendritic cells were identified as CD11bhi (CD90/B220/CD49b/NK1.1/Ly-6G)lo. (A) Representative dot plots from individual mice within the monocyte/macrophage/dendritic cell gate depict Ly-6Chi monocytes (Ly-6Chi [F4/80/I-Ab/CD11c]lo), Ly-6Clo monocytes (Ly-6Clo [F4/80/I-Ab/CD11c]lo), and macrophages/dendritic cells (Ly-6Clo [F4/80/I-Ab/CD11c]hi) in healthy hearts and within the infarct at specified days after MI. Percentages of cells are shown as the mean ± the SEM. (B) Relative percentage of monocytes and macrophages/dendritic cells. (C) Relative percentage of Ly-6Chi and -6Clo monocytes. (D) Total number of neutrophils per milligram of tissue. (E) Total number of monocytes and macrophages/dendritic cells per milligram of tissue. (F) Total number of Ly-6Chi and -6Clo monocytes per mg tissue. (G) Time course of leukocyte infiltration to infarct. The mean and the SEM are shown. Results are pooled from 6 independent experiments with 3–10 mice per group.
Figure 1. The ischemic myocardium mobilizes Ly-6Chi and -6Clo monocytes in two distinct phases. Cell suspensions from healthy hearts or infarcts of C57BL/6 mice were stained with anti-CD11b, -CD90, -B220, -CD49b, -NK1.1, -Ly-6G, -Ly-6C, -F4/80, -I-Ab, and -CD11c mAbs. Monocytes/macrophages/dendritic cells were identified as CD11bhi (CD90/B220/CD49b/NK1.1/Ly-6G)lo. (A) Representative dot plots from individual mice within the monocyte/macrophage/dendritic cell gate depict Ly-6Chi monocytes (Ly-6Chi [F4/80/I-Ab/CD11c]lo), Ly-6Clo monocytes (Ly-6Clo [F4/80/I-Ab/CD11c]lo), and macrophages/dendritic cells (Ly-6Clo [F4/80/I-Ab/CD11c]hi) in healthy hearts and within the infarct at specified days after MI. Percentages of cells are shown as the mean ± the SEM. (B) Relative percentage of monocytes and macrophages/dendritic cells. (C) Relative percentage of Ly-6Chi and -6Clo monocytes. (D) Total number of neutrophils per milligram of tissue. (E) Total number of monocytes and macrophages/dendritic cells per milligram of tissue. (F) Total number of Ly-6Chi and -6Clo monocytes per mg tissue. (G) Time course of leukocyte infiltration to infarct. The mean and the SEM are shown. Results are pooled from 6 independent experiments with 3–10 mice per group.CC BY-NC-SA · PubMed Central
Figure 2. The ischemic myocardium sequentially recruits circulating Ly-6Chi and -6Clo monocytes. (A) Number of total leukocytes in peripheral blood of C57BL/6 mice before MI and at the onset of phase I (day 1 after MI) and phase II (day 4). (B) Number of circulating Ly-6Chi and -6Clo monocytes at the same time points. Values in the top right quadrants indicate the ratio between the two subsets. (C) In vivo cardiac accumulation of 111In-oxine-labeled Ly-6Chi and -6Clo monocytes 24 h after adoptive transfer on day 0 (phase I) and day 4 (phase II). Values in the top right quadrants indicate the ratio between the two subsets. (D) Adoptively transferred 111In-oxine–labeled Ly-6Chi monocytes compete with endogenous Ly-6Chi monocytes. Increased numbers of endogenous circulating Ly-6Chi monocytes (x axis) decrease the ratio between transferred and endogenous Ly-6Chi monocytes (label frequency, y axis) that migrated into the peritoneal cavity of mice with peritonitis (Table S1). (E) Pie graph representing the relative proportion of Ly-6Chi and -6Clo monocyte subsets expected to accumulate in infarct tissue, based on the mean abundance of each subset in peripheral blood (B) and the intrinsic capacity of circulating cells from each subset to accumulate at infarct tissue (C). Data represent three independent experiments and are shown as the mean ± the SEM. Table S1 is available at http://www.jem.org/cgi/content/full/jem.20070885/DC1.
Figure 2. The ischemic myocardium sequentially recruits circulating Ly-6Chi and -6Clo monocytes. (A) Number of total leukocytes in peripheral blood of C57BL/6 mice before MI and at the onset of phase I (day 1 after MI) and phase II (day 4). (B) Number of circulating Ly-6Chi and -6Clo monocytes at the same time points. Values in the top right quadrants indicate the ratio between the two subsets. (C) In vivo cardiac accumulation of 111In-oxine-labeled Ly-6Chi and -6Clo monocytes 24 h after adoptive transfer on day 0 (phase I) and day 4 (phase II). Values in the top right quadrants indicate the ratio between the two subsets. (D) Adoptively transferred 111In-oxine–labeled Ly-6Chi monocytes compete with endogenous Ly-6Chi monocytes. Increased numbers of endogenous circulating Ly-6Chi monocytes (x axis) decrease the ratio between transferred and endogenous Ly-6Chi monocytes (label frequency, y axis) that migrated into the peritoneal cavity of mice with peritonitis (Table S1). (E) Pie graph representing the relative proportion of Ly-6Chi and -6Clo monocyte subsets expected to accumulate in infarct tissue, based on the mean abundance of each subset in peripheral blood (B) and the intrinsic capacity of circulating cells from each subset to accumulate at infarct tissue (C). Data represent three independent experiments and are shown as the mean ± the SEM. Table S1 is available at http://www.jem.org/cgi/content/full/jem.20070885/DC1.CC BY-NC-SA · PubMed Central
Figure 3. Sequential recruitment of Ly-6Chi and -6Clo monocytes depends on CCR2 and CX3CR1, respectively. (A) RT-PCR expression profile of MCP-1, MIP-1α, fractalkine, and VCAM-1 in the heart tissue before MI and during phase I (day 1) and II (day 4). (B) Monocyte subset expression profile of CCR2, CCR5, CX3CR1 (for review see reference [29]), and VLA-4 (as assessed by flow cytometry). (C) Number of Ly-6Chi and -6Clo monocytes in infarcts of wild-type, CCR2−/−, and CX3CR1−/− mice in phase I (day 1) and II (day 7). Numbers are normalized to milligrams of tissue. The mean and the SEM are shown. n = 3–5. *, P < 0.05.
Figure 3. Sequential recruitment of Ly-6Chi and -6Clo monocytes depends on CCR2 and CX3CR1, respectively. (A) RT-PCR expression profile of MCP-1, MIP-1α, fractalkine, and VCAM-1 in the heart tissue before MI and during phase I (day 1) and II (day 4). (B) Monocyte subset expression profile of CCR2, CCR5, CX3CR1 (for review see reference [29]), and VLA-4 (as assessed by flow cytometry). (C) Number of Ly-6Chi and -6Clo monocytes in infarcts of wild-type, CCR2−/−, and CX3CR1−/− mice in phase I (day 1) and II (day 7). Numbers are normalized to milligrams of tissue. The mean and the SEM are shown. n = 3–5. *, P < 0.05.CC BY-NC-SA · PubMed Central
Figure 4. Ly-6Chi and -6Clo monocytes commit for different functions. Relative phagocytic activity, MMP activity, cathepsin activity, TNF-α production (with or without stimulation with PMA/ionomycin), and VEGF expression in Ly-6Chi monocytes (shaded histogram), Ly-6Clo monocytes (black line), and control CD11b− cells (gray line) retrieved from the ischemic myocardium. The mean and the SEM are shown. n = 3–5. *, P < 0.05; **, P < 0.01.
Figure 4. Ly-6Chi and -6Clo monocytes commit for different functions. Relative phagocytic activity, MMP activity, cathepsin activity, TNF-α production (with or without stimulation with PMA/ionomycin), and VEGF expression in Ly-6Chi monocytes (shaded histogram), Ly-6Clo monocytes (black line), and control CD11b− cells (gray line) retrieved from the ischemic myocardium. The mean and the SEM are shown. n = 3–5. *, P < 0.05; **, P < 0.01.CC BY-NC-SA · PubMed Central
Figure 5. In vivo relevance of the biphasic response to healing. (A) Representative dot plots from individual mice depict Ly-6Chi monocytes (bottom right), Ly-6Clo monocytes (bottom left), and macrophages/dendritic cells (top left) at the infarct after depletion of circulating monocytes with clodronate-loaded liposomes (Clo-Lip). Mice were analyzed on day 4 (Clo-Lip injection on day 0; depletion of phase I) and on day 7 (Clo-Lip injection on day 3; depletion of phase II). Control animals (Ø) did not receive Clo-Lip. Percentages of cells are shown as the mean ± the SEM. (B) Total number of monocytes per milligram of tissue at the infarct before MI, at the end of phase I (day 4) and during phase II (day 7), in the absence (–) or presence (+) of Clo-Lip. The mean and the SEM are shown. n = 3–5. (C) Immunohistochemical analysis 7 d after MI depicts representative infarct sections from undepleted (Ø), phase I–depleted (I), and phase II–depleted (II) C57BL/6 mice. Representative sections stained with anti–Mac-3, anti–NIMP-R14, Masson, α-actin, PSR, and anti-CD31 are shown. The mean and the SEM are shown. n = 7. (D) Immunohistochemistry depicts representative infarct sections from apoE−/− mice 7 d after MI. The mean and the SEM are shown. n = 5. *, P < 0.05; **, P < 0.01. Bars: (Mac-3, NIMP-R14, α-actin, and CD31) 20 μm; (PSR and Masson) 100 μm.
Figure 5. In vivo relevance of the biphasic response to healing. (A) Representative dot plots from individual mice depict Ly-6Chi monocytes (bottom right), Ly-6Clo monocytes (bottom left), and macrophages/dendritic cells (top left) at the infarct after depletion of circulating monocytes with clodronate-loaded liposomes (Clo-Lip). Mice were analyzed on day 4 (Clo-Lip injection on day 0; depletion of phase I) and on day 7 (Clo-Lip injection on day 3; depletion of phase II). Control animals (Ø) did not receive Clo-Lip. Percentages of cells are shown as the mean ± the SEM. (B) Total number of monocytes per milligram of tissue at the infarct before MI, at the end of phase I (day 4) and during phase II (day 7), in the absence (–) or presence (+) of Clo-Lip. The mean and the SEM are shown. n = 3–5. (C) Immunohistochemical analysis 7 d after MI depicts representative infarct sections from undepleted (Ø), phase I–depleted (I), and phase II–depleted (II) C57BL/6 mice. Representative sections stained with anti–Mac-3, anti–NIMP-R14, Masson, α-actin, PSR, and anti-CD31 are shown. The mean and the SEM are shown. n = 7. (D) Immunohistochemistry depicts representative infarct sections from apoE−/− mice 7 d after MI. The mean and the SEM are shown. n = 5. *, P < 0.05; **, P < 0.01. Bars: (Mac-3, NIMP-R14, α-actin, and CD31) 20 μm; (PSR and Masson) 100 μm.CC BY-NC-SA · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 64 references

Research works printed but not linked: 5

  1. 1987, Circulation., 75, IV93
  2. 2006, Circulation., 114, I94
  3. 2007, J. Clin. Invest., 117, 89
  4. 2006, Nat. Immunol., 7, 311
  5. 2002, J. Am. Coll. Cardiol., 39, 241

Cited by

See all 2,300

Metadata

Authors
Nahrendorf, M., Swirski, F. K., Aikawa, E., Stangenberg, L., Wurdinger, T., Figueiredo, J.-L., Libby, P., Weissleder, R., & Pittet, M. J.
Affiliations
  • Center for Systems Biology (US)
  • 2Center for Molecular Imaging Research, and
  • Brigham and Women's Hospital (US)
  • Harvard University (US)
  • 1Center for Systems Biology,
Venue
The Journal of Experimental Medicine
Published
2007-11-19
Volume
204
Issue
12
Pages
3037-3047
ISSN
  • 0022-1007 (ISSN-L)
  • 1540-9538
OpenAlex
W2135647797
Cited by
2,300
References
64
Citations by year
2026: 92 · 2025: 97 · 2024: 136 · 2023: 126 · 2022: 134 · 2021: 143 · 2020: 150 · 2019: 147 · 2018: 139 · 2017: 160 · 2016: 137 · 2015: 145 · 2014: 145 · 2013: 140 · 2012: 130
FWCI
42.51
Type
journal article
Language
en
Open access
Locations
  • The Journal of Experimental Medicine (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
  • Archive ouverte UNIGE (University of Geneva) (publishedVersion, other-oa)
Funders
  • American Heart Association
  • National Institutes of Health (5r01hl034636-23)
  • U.S. Public Health Service (P01 A154904)
  • National Heart, Lung, and Blood Institute (U01HL080731, R01HL34636, R01-HL034636)
  • National Cancer Institute (P01CA069246, R24 CA69246)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
  • Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
Keywords
monocyte heterogeneity, CCR2, CX3CR1, chemokine expression, monocyte recruitment, phagocytosis, myofibroblast accumulation, angiogenesis, collagen deposition, vascular endothelial growth factor, atherosclerosis, ventricular remodeling, ischemic injury
MeSH terms
Animals, Flow Cytometry, Heart Injuries, Kinetics, Mice, Inbred C57BL, Monocytes, Myocardial Infarction, Neutrophils, Time Factors, Wound Healing, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. https://app.cochat.ai/papers/10.1084/jem.20070885
The paper
Nahrendorf, M., Swirski, F. K., Aikawa, E., Stangenberg, L., Wurdinger, T., Figueiredo, J.-L., Libby, P., Weissleder, R., & Pittet, M. J. (2007). The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. The Journal of Experimental Medicine. https://doi.org/10.1084/jem.20070885

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.